Dysregulated apoptosis and NFκB expression in COPD subjects

BackgroundThe abnormal regulation of neutrophil apoptosis may contribute to the ineffective resolution of inflammation in chronic lung diseases. Multiple signalling pathways are implicated in regulating granulocyte apoptosis, in particular, NFκB (nuclear factor-kappa B) signalling which delays constitutive neutrophil apoptosis. Although some studies have suggested a dysregulation in the apoptosis of airway cells in chronic obstructive pulmonary disease (COPD), no studies to date have directly investigated if NFκB is associated with apoptosis of airway neutrophils from COPD patients. The objectives of this study were to examine spontaneous neutrophil apoptosis in stable COPD subjects (n = 13), healthy smoking controls (n = 9) and non-smoking controls (n = 9) and to investigate whether the neutrophil apoptotic process in inflammatory conditions is associated with NFκB activation.MethodsAnalysis of apoptosis in induced sputum was carried out by 3 methods; light microscopy, Annexin V/Propidium iodide and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. Activation of NFκB was assessed using a flow cytometric method and the phosphorylation state of IκBα was carried out using the Bio-Rad Bio-Plex phosphoprotein IκBα assay.ResultsFlow cytometric analysis showed a significant reduction in the percentage of sputum neutrophils undergoing spontaneous apoptosis in healthy smokers and subjects with COPD compared to non-smokers (p < 0.001). Similar findings were demonstrated using the Tunel assay and in the morphological identification of apoptotic neutrophils. A significant increase was observed in the expression of both the p50 (p = 0.006) and p65 (p = 0.006) subunits of NFκB in neutrophils from COPD subjects compared to non-smokers.ConclusionThese results demonstrate that apoptosis is reduced in the sputum of COPD subjects and in healthy control smokers and may be regulated by an associated activation of NFκB.

[1]  I. Pavord,et al.  Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis , 2007, European Respiratory Journal.

[2]  Stephen T Holgate,et al.  Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[3]  David M. Rothwarf,et al.  The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.

[4]  Dirkje S Postma,et al.  Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.

[5]  C. Vallan,et al.  THE TUNEL ASSAY IN THE DIAGNOSIS OF GRAFT‐VERSUS‐HOST DISEASE: CAVEATS FOR INTERPRETATION , 2000, Pathology.

[6]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[7]  G E Marti,et al.  Quantitative flow cytometry: history, practice, theory, consensus, inter-laboratory variation and present status. , 2002, Cytotherapy.

[8]  T. Takano,et al.  Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. , 1996, Journal of immunology.

[9]  D. Postma,et al.  The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation , 2004, European Respiratory Journal.

[10]  P. Barnes,et al.  Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. , 1997, American journal of respiratory and critical care medicine.

[11]  B. Kraupp,et al.  In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.

[12]  W. MacNee,et al.  The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[13]  F. Herrmann,et al.  Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. , 1992, Blood.

[14]  C. Gélinas,et al.  To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.

[15]  G. Bedoya,et al.  Dexamethasone Inhibits Apoptosis of Human Neutrophils Induced by Reactive Oxygen Species , 2002, Inflammation.

[16]  I. Vancurova,et al.  NF-κB Regulation in Human Neutrophils by Nuclear IκBα: Correlation to Apoptosis1 , 2002, The Journal of Immunology.

[17]  X. M. Sun,et al.  Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. , 1992, The Biochemical journal.

[18]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[19]  I. Vancurova,et al.  NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. , 2002, Journal of immunology.

[20]  A. van der Vliet,et al.  Inhibition of neutrophil apoptosis by acrolein: a mechanism of tobacco-related lung disease? , 2001, American journal of physiology. Lung cellular and molecular physiology.

[21]  I. Adcock,et al.  Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD , 2002, European Respiratory Journal.

[22]  S. Grimm,et al.  Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis , 1996, The Journal of cell biology.

[23]  S. Foulds.  Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells. , 1997, Cytometry.

[24]  K. Nishigaki,et al.  An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. , 1998, Respiratory medicine.

[25]  Céline Gélinas,et al.  To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis. , 2003, Oncogene.

[26]  L. Fabbri,et al.  Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. , 2003, Thorax.

[27]  B. Beghé,et al.  Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease , 1998, Thorax.

[28]  Gert Folkerts,et al.  Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages , 2006, Respiratory research.

[29]  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. , 1997, Thorax.

[30]  P. Tak,et al.  NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.

[31]  C. Ward,et al.  Role of neutrophil apoptosis in the resolution of pulmonary inflammation. , 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[32]  S. Yasumura,et al.  Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[33]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[34]  H. Lode,et al.  Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD , 2004, European Respiratory Journal.

[35]  E. Moore,et al.  Interleukin-6 delays neutrophil apoptosis. , 1996, Archives of surgery.

[36]  D. Katz,et al.  Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.

[37]  E. Moore,et al.  Interleukin‐6 suppression of neutrophil apoptosis is neutrophil concentration dependent , 1995, Journal of leukocyte biology.

[38]  C. Haslett,et al.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators , 1993, Journal of leukocyte biology.

[39]  I. Pavord,et al.  The use of induced sputum to investigate airway inflammation. , 1997, Thorax.

[40]  A. Agustí,et al.  Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD. , 2004, Chest.

[41]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[42]  R. Djukanović,et al.  Airway neutrophilia in COPD is not associated with increased neutrophil survival , 2006, European Respiratory Journal.

[43]  L. Glasser,et al.  Programmed cell death of the normal human neutrophil: An in vitro model of senescence , 1994, Microscopy research and technique.

[44]  J. Elborn,et al.  Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. , 2002, Chest.

[45]  A. Martelli,et al.  The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. , 1993, Biochemical and biophysical research communications.

[46]  S. Leuenroth,et al.  Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. , 1998, Surgery.

[47]  P. Barnes,et al.  β2-Agonists Potentiate Corticosteroid-Induced Neutrophil Survival , 2008, COPD.

[48]  A. Prince,et al.  Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. , 2002, American journal of respiratory cell and molecular biology.

[49]  P. Vogt,et al.  Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Hall,et al.  Assessing apoptosis: a critical survey. , 1999, Endocrine-related cancer.

[51]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[52]  T. Ito,et al.  Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. , 1999, American journal of respiratory cell and molecular biology.

[53]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[54]  H. Simms,et al.  Paracrine Suppression of Apoptosis by Cytokine-Stimulated Neutrophils Involves Divergent Regulation Of NF-&Kgr;B, Bcl-XL, and Bak , 2002, Shock.

[55]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[56]  E. Chi,et al.  Neutrophil apoptosis in the acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.